EPISODE · May 5, 2025 · 41 MIN
GLP-1 Medications and Weight Loss: What You Need To Know About Ozempic, Wegovy and Zepbound
from The Healthy, Real Food®️ Podcast with Erin Hart, BSN, RN · host Erin Hart, BSN, RN
GLP-1 Medications & Weight Loss: Everything You Need to KnowCurious about the buzz surrounding weight loss medications like Ozempic and Wegovy? In this episode (#197) of the Healthy Real Food Podcast, we dive into the science-backed facts and expert insights on GLP-1 medications, including semaglutide and tirzepatide. Discover how these medications work, their benefits, risks, and the essential lifestyle changes needed to make them effective. Perfect for anyone considering these medications or looking for honest, evidence-based information on sustainable weight loss. Join us for a comprehensive discussion tailored to empower your health journey!00:00 Introduction to Weight Loss Medications01:45 Understanding GLP-1 Medications03:20 Science and History of GLP-1 Medications06:14 Benefits and Risks of GLP-1 Medications08:55 Proper Use and Misuse of GLP-1 Medications11:03 Maintaining Muscle and Metabolism20:21 Myths and Misconceptions22:46 Side Effects and Costs28:04 Personal Experiences and Final Thoughts37:18 Summary and ConclusionReady to lose weight for the last time? Ready to Stop Starting Over?If you’re tired of the dieting rollercoaster and want a clear, customized plan that actually works... let’s talk.Get your free 1 hour weight loss strategy session with me on Zoom to help you break through what’s keeping you stuck, create a plan that fits your life and start seeing results you can actually sustain.Click here to book your free strategy session with me now: www.healthyrealfood.comYou don’t have to figure this out alone.This is your year. Let’s make it happen...together.
Embed this episode
NOW PLAYING
GLP-1 Medications and Weight Loss: What You Need To Know About Ozempic, Wegovy and Zepbound
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.